MedTrace Logo

A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)

NCT07761130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2026-08-12

No results posted yet for this study

Summary

The goal of this study is to learn if the Improving Healthand Lifestyle Programme (iHeLP) is feasible and acceptable to stroke survivors. The main questions it aims to answer are:

* Is iHeLP feasible to deliver?
* Is iHeLP acceptable to people who take part?
* What effect does iHeLP have on the lifestyle behaviours of participants?

Participants will:

* Take part in the iHeLP intervention (consists of a one-to-one interview with the facilitator followed by six weekly group sessions with other stroke survivors)
* Complete questionnaires about their lifestyle during the one-to-one interview and after the intervention.
* Participate in a focus group to discuss their experiences and perceptions of iHeLP.

Conditions

Interventions

BEHAVIORAL

The Improving Health and Lifestyle Programme (iHeLP)

The Improving Health and Lifestyle Programme (iHeLP) is an evidence- and theory-informed secondary prevention intervention to support behaviour change and healthy lifestyle participation after stroke. Participants will complete a one-to-one interview (approximately 60 minutes) with the programme facilitator to establish health status and set personalised lifestyle goals. Participants then take part in six weekly group in-person sessions lasting approximately 2 hours each, with each intervention session consisting of six core components: skills training, education, physical activity participation, goal-setting, supported emotional self-regulation and peer learning.

Sponsors & Collaborators

  • Health Research Board, Ireland

    collaborator OTHER

  • University of Limerick

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-09
Primary Completion
2026-06-10
Completion
2026-06-10

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07761130 on ClinicalTrials.gov